DocWire News Content Partners
Advertisement
The Latest From Our Partners
The Oncology Brothers were live at ASCO 2023 to discuss findings from the TROPiCS-02 study.
ASCO 2023: The Oncology Brothers Discuss ADAURA Trial Findings of Osimertinib for EGFR-Mutated NSCLC
The Oncology Brothers discuss findings from the phase 3 ADAURA trial.The following question refers to Section 7.1 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
Dr. Devesh Rai of The CardioNerds discusses the first study comparing CAC to that of prior ASCVD.
The CardioNerds ponder another important question related to heart failure with Dr. Shelley Zieroth.
A large registry of TAVR procedures shows that coronary obstruction following TAVR is rare, carries a high fatality rate.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get insights and commentary from our partners straight to your inbox.